DalsnaFinance › IPOs › Jyong Biotech › IPO
Jyong Biotech Ltd. completed its initial public offering on NASDAQ on June 17, 2025, pricing at $7.50 a share.
| Ticker | MENS |
|---|---|
| Exchange | NASDAQ |
| Status | Completed |
| Listing date | June 17, 2025 |
| Offering price | $7.50 |
| Shares offered | 2,666,667 |
| Total raised | $20M |
Jyong Biotech Ltd. sold 2,666,667 shares at $7.50 each on NASDAQ. Multiplied out, that is $20 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $20 million total recorded for the deal.
Measured by money raised, Jyong Biotech Ltd. was tied for the 410th largest (level with 4 other deals) of 473 completed IPOs with a recorded deal size that this site tracks since October 5, 2024. The median deal in the same window raised $200 million.
Among the 342 listings on NASDAQ alone, it is tied for the 304th largest (level with 3 other listings).
June 2025 saw 24 completed IPOs in the site's data; by amount raised, Jyong Biotech Ltd. was the 20th largest of the 24 deals with a recorded size.
Its $7.50 offer price was tied for the 416th highest (level with 1 other listing) of the 479 listings in the window with a recorded price. A share price on its own says nothing about a company's value; it depends on how many shares exist.
Jyong Biotech Ltd. — quote, profile and latest news →
Source: SEC EDGAR filings for Jyong Biotech Ltd.. This page is general information, not investment advice.